Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GMVD

G Medical Innovations (GMVD) Stock Price, News & Analysis

G Medical Innovations logo

About G Medical Innovations Stock (NASDAQ:GMVD)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.16
$0.38
52-Week Range
N/A
Volume
2.86 million shs
Average Volume
1.13 million shs
Market Capitalization
$355,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures ECG data continuously for up to 14 days. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was incorporated in 2014 and is headquartered in Rehovot, Israel.

Receive GMVD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for G Medical Innovations and its competitors with MarketBeat's FREE daily newsletter.

GMVD Stock News Headlines

“You all just got a lot richer”
Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crashes. Do you think that’s an accident? When he threatens to “End the Fed” do you think he doesn’t know banking stocks will benefit? What about when he tells his followers, “Now is a good time to buy,” hours before relaxing tariffs and sending the market soaring? Is that an accident? Larry Benedict doesn’t think so. He thinks Trump knows what he’s doing… and believes he’s found the perfect tickers for everyday Americans to take advantage next time he triggers a big move.
G Medical Innovations Holdings Ltd GMVDF
Why Is G Medical Innovations (GMVD) Stock Up 32% Today?
See More Headlines

GMVD Stock Analysis - Frequently Asked Questions

G Medical Innovations's stock reverse split on Saturday, November 19th 2022. The 1-35 reverse split was announced on Saturday, November 19th 2022. The number of shares owned by shareholders was adjusted after the market closes on Saturday, November 19th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

G Medical Innovations (GMVD) raised $8 million in an initial public offering on Friday, June 25th 2021. The company issued 3,000,000 shares at a price of $5.00-$0.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that G Medical Innovations investors own include HubSpot (HUBS), Tesla (TSLA), Pfizer (PFE), Diamondback Energy (FANG), ForgeRock (FORG) and Netflix (NFLX).

Company Calendar

Today
6/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:GMVD
Fax
N/A
Employees
84
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.42 million
Price / Cash Flow
N/A
Book Value
($3.21) per share
Price / Book
N/A

Miscellaneous

Free Float
1,235,000
Market Cap
$355,000.00
Optionable
Not Optionable
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:GMVD) was last updated on 6/3/2025 by MarketBeat.com Staff
From Our Partners